Mercury (element): Difference between revisions

Mercury (element)
	Adult Indications & Dosage
	Pediatric Indications & Dosage
	Contraindications
	Warnings & Precautions
	Adverse Reactions
	Drug Interactions
	Use in Specific Populations
	Administration & Monitoring
	Overdosage
	Pharmacology
	Clinical Studies
	How Supplied
	Images
	Patient Counseling Information
	Precautions with Alcohol
	Brand Names
	Look-Alike Names

VisualWikitext

Latest revision as of 16:40, 20 August 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Mercury (element) is a metal that is FDA approved for the treatment of for the temporary relief of dizziness, feeling discouraged, depression, painful dryness of throat. Common adverse reactions include hypersensitivity and nephrotoxicity.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

FOR THE TEMPORARY RELIEF OF DIZZINESS,FEELING DISCOURAGED, DEPRESSION, PAINFUL DRYNESS OF THROAT.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Mercury (element) in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Mercury (element) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Mercury (element) in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Mercury (element) in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Mercury (element) in pediatric patients.

Contraindications

There is limited information regarding Mercury (element) Contraindications in the drug label.

Warnings

STOP USE AND CALL A DOCTOR IF SYMPTOMS PERSIST OR WORSEN. IF PREGNANT ORBREAST-FEEDING CONSULT A HEALTHCARE PROFESSIONAL BEFORE USE.
CONTAINS ALCOHOL, IN CASE OF ACCIDENTAL OVERDOSE, CONSULT A POISON CONTROL CENTER IMMEDIATELY

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Mercury (element) in the drug label.

Postmarketing Experience

Nephrotoxicity and hypersensitivity

Drug Interactions

There is limited information regarding Mercury (element) Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

Pregnancy Category

Pregnancy Category (AUS):

Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Mercury (element) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Mercury (element) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Mercury (element) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Mercury (element) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Mercury (element) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Mercury (element) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Mercury (element) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Mercury (element) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Mercury (element) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Mercury (element) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Mercury (element) in patients who are immunocompromised.

Administration and Monitoring

Administration

Oral

Monitoring

There is limited information regarding Monitoring of Mercury (element) in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Mercury (element) in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Mercury (element) in the drug label.

Pharmacology

There is limited information regarding Mercury (element) Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Mercury (element) Mechanism of Action in the drug label.

Structure

There is limited information regarding Mercury (element) Structure in the drug label.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Mercury (element) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Mercury (element) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Mercury (element) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Mercury (element) in the drug label.

How Supplied

There is limited information regarding Mercury (element) How Supplied in the drug label.

Storage

KEEP OUT OF REACH OF CHILDREN

Images

Drug Images

{{#ask: Page Name::Mercury (element) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Mercury (element) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

DIRECTIONS: ORALLY 6 DROPS ORALLY, 4 TIMES A DAY.FOR AGES 2 TO ADULT

Precautions with Alcohol

Alcohol-Mercury (element) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

TOTAL MERCURY ®^[1]

Look-Alike Drug Names

There is limited information regarding Mercury (element) Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

↑ "TOTAL MERCURY- mercury liquid".

{{#subobject:

 |Label Page=Mercury (element)
 |Label Name=Mercury 01.jpg

}}

{{#subobject:

 |Label Page=Mercury (element)
 |Label Name=DailyMed - TOTAL MERCURY- mercury liquid  .png

}}

[1] "TOTAL MERCURY- mercury liquid".

[1]

@@ Line 1: / Line 1: @@
 {{DrugProjectFormSinglePage
-|authorTag=<!--Overview-->
+|authorTag={{Ammu}}
+|genericName=mercury
 |aOrAn=a
-|hasBlackBoxWarning=Yes
+|drugClass=[[metal]]
-|adverseReactions=<!--Black Box Warning-->
+|indicationType=treatment
+|indication=for the temporary relief of [[dizziness]], feeling discouraged, [[depression]], painful dryness of [[throat]]
+|adverseReactions=[[hypersensitivity]] and [[nephrotoxicity]]
 |blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span>
 |blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
@@ Line 12: / Line 15: @@
 <!--FDA-Labeled Indications and Dosage (Adult)-->
-|fdaLIADAdult======Condition1=====
+|fdaLIADAdult=* FOR THE TEMPORARY RELIEF OF DIZZINESS,FEELING  DISCOURAGED, DEPRESSION, PAINFUL DRYNESS OF THROAT.
+|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
-* Dosing Information
-:* Dosage
-=====Condition2=====
-* Dosing Information
-:* Dosage
-=====Condition3=====
-* Dosing Information
-:* Dosage
-=====Condition4=====
-* Dosing Information
-:* Dosage
-<!--Off-Label Use and Dosage (Adult)-->
-<!--Guideline-Supported Use (Adult)-->
-|offLabelAdultGuideSupport======Condition1=====
-* Developed by:
-* Class of Recommendation:
-* Strength of Evidence:
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 <!--Non–Guideline-Supported Use (Adult)-->
-|offLabelAdultNoGuideSupport======Condition1=====
+|offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 <!--Pediatric Indications and Dosage-->
 <!--FDA-Labeled Indications and Dosage (Pediatric)-->
-|fdaLIADPed======Condition1=====
+|fdaLIADPed=There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
 <!--Off-Label Use and Dosage (Pediatric)-->
 <!--Guideline-Supported Use (Pediatric)-->
-|offLabelPedGuideSupport======Condition1=====
+|offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
-* Developed by:
-* Class of Recommendation:
-* Strength of Evidence:
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 <!--Non–Guideline-Supported Use (Pediatric)-->
-|offLabelPedNoGuideSupport======Condition1=====
+|offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 <!--Contraindications-->
-|contraindications=* Condition1
+|warnings=* STOP USE AND CALL A DOCTOR IF SYMPTOMS PERSIST OR WORSEN. IF PREGNANT ORBREAST-FEEDING CONSULT A HEALTHCARE PROFESSIONAL BEFORE USE.
+* CONTAINS ALCOHOL, IN CASE OF ACCIDENTAL OVERDOSE, CONSULT A POISON CONTROL CENTER IMMEDIATELY
-<!--Warnings-->
-|warnings=* Description
-====Precautions====
-* Description
-<!--Adverse Reactions-->
-<!--Clinical Trials Experience-->
 |clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
+|postmarketing=[[Nephrotoxicity]] and [[hypersensitivity]]
-=====Body as a Whole=====
+|drugInteractions=<!--Use in Specific Populations-->
-=====Cardiovascular=====
-=====Digestive=====
-=====Endocrine=====
-=====Hematologic and Lymphatic=====
-=====Metabolic and Nutritional=====
-=====Musculoskeletal=====
-=====Neurologic=====
-=====Respiratory=====
-=====Skin and Hypersensitivy Reactions=====
-=====Special Senses=====
-=====Urogenital=====
-=====Miscellaneous=====
-<!--Postmarketing Experience-->
-|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
-=====Body as a Whole=====
-=====Cardiovascular=====
-=====Digestive=====
-=====Endocrine=====
-=====Hematologic and Lymphatic=====
-=====Metabolic and Nutritional=====
-=====Musculoskeletal=====
-=====Neurologic=====
-=====Respiratory=====
-=====Skin and Hypersensitivy Reactions=====
-=====Special Senses=====
-=====Urogenital=====
-=====Miscellaneous=====
-<!--Drug Interactions-->
-|drugInteractions=* Drug
-:* Description
-<!--Use in Specific Populations-->
 |useInPregnancyFDA=* '''Pregnancy Category'''
 |useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
@@ Line 264: / Line 56: @@
 <!--Administration and Monitoring-->
-|administration=* Oral
+|administration=* [[Oral]]
+|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
-* Intravenous
-|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
-* Description
 <!--IV Compatibility-->
@@ Line 275: / Line 65: @@
 <!--Overdosage-->
-|overdose====Acute Overdose===
+|overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
-====Signs and Symptoms====
-* Description
-====Management====
-* Description
-===Chronic Overdose===
-There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
 <!--Pharmacology-->
@@ Line 293: / Line 71: @@
 <!--Drug box 2-->
 |drugBox=<!--Mechanism of Action-->
-|mechAction=*
+|mechAction=<!--Structure-->
+|structure=<!--Pharmacodynamics-->
-<!--Structure-->
-|structure=*
-: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
-<!--Pharmacodynamics-->
 |PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
@@ Line 313: / Line 85: @@
 <!--How Supplied-->
-|howSupplied=*
+|storage=* KEEP OUT OF REACH OF CHILDREN
 |packLabel=<!--Patient Counseling Information-->
-|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
+|fdaPatientInfo=* DIRECTIONS: ORALLY 6 DROPS ORALLY, 4 TIMES A DAY.FOR AGES 2 TO ADULT
-<!--Precautions with Alcohol-->
 |alcohol=* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
 <!--Brand Names-->
-|brandNames=* ®<ref>{{Cite web | title =  | url =  }}</ref>
+|brandNames=*TOTAL MERCURY ®<ref>{{Cite web | title =TOTAL MERCURY- mercury liquid   | url = http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a8f0780c-70fa-4b88-ac46-e37e4ed37f97 }}</ref>
 <!--Look-Alike Drug Names-->
-|lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
-<!--Drug Shortage Status-->
 |drugShortage=
-}}
-{{PillImage
-|fileName=No image.jpg
 }}
 {{LabelImage
-|fileName={{PAGENAME}}11.png
+|fileName=Mercury 01.jpg
 }}
 {{LabelImage
-|fileName={{PAGENAME}}11.png
+|fileName=DailyMed - TOTAL MERCURY- mercury liquid  .png
 }}
 <!--Pill Image-->
@@ Line 351: / Line 115: @@
 [[Category:Drug]]
+[[Category:Chemical elements]]
+[[Category:Mercury (element)| ]]
+[[Category:Occupational safety and health]]
+[[Category:Transition metals]]
+[[Category:Coolants]]
+[[Category:Neurotoxins]]

Mercury (element): Difference between revisions

Latest revision as of 16:40, 20 August 2015

Disclaimer

Overview

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

Non–Guideline-Supported Use

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Non–Guideline-Supported Use

Contraindications

Warnings

Adverse Reactions

Clinical Trials Experience

Postmarketing Experience

Drug Interactions

Use in Specific Populations

Pregnancy

Labor and Delivery

Nursing Mothers

Pediatric Use

Geriatic Use

Gender

Race

Renal Impairment

Hepatic Impairment

Females of Reproductive Potential and Males

Immunocompromised Patients

Administration and Monitoring

Administration

Monitoring

IV Compatibility

Overdosage

Pharmacology

Mechanism of Action

Structure

Pharmacodynamics

Pharmacokinetics

Nonclinical Toxicology

Clinical Studies

How Supplied

Storage

Images

Drug Images

Package and Label Display Panel

Patient Counseling Information

Precautions with Alcohol

Brand Names

Look-Alike Drug Names

Drug Shortage Status

Price

References

Navigation menu